OTCMKTS:HYBT Heyu Biological Technology (HYBT) Stock Price, News & Analysis $0.14 0.00 (0.00%) As of 07/1/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Heyu Biological Technology Stock (OTCMKTS:HYBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HYBT alerts:Sign Up Key Stats Today's Range$0.14▼$0.1450-Day Range$0.00▼$0.2452-Week Range$0.00▼$3.40Volume10 shsAverage Volume5,371 shsMarket Capitalization$14.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation. Read More Receive HYBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heyu Biological Technology and its competitors with MarketBeat's FREE daily newsletter. Email Address HYBT Stock News Headlines'It is biological in origin': 1st analysis of weird golden orb from ocean floor leaves scientists stumpedMay 17, 2024 | msn.comFujian Aonong Biological Technology Group Incorporation Ltd (603363)January 10, 2024 | investing.comAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.July 2 at 2:00 AM | Paradigm Press (Ad)Shanghai Haohai Biological Technology Co Ltd (5HB)December 6, 2023 | investing.comJiangsu Chinagreen Biological Technology Co. Ltd. AOctober 10, 2023 | wsj.comHeyu Biological Technology Corporation (HYBT)July 7, 2023 | finance.yahoo.comShanghai Bio-heart Biological Technology Co Ltd Class HJune 30, 2023 | morningstar.comMShanghai Haohai Biological Technology Co Ltd Shs -H- Unitary 144A/Reg SMay 9, 2023 | morningstar.comMSee More Headlines HYBT Stock Analysis - Frequently Asked Questions How have HYBT shares performed this year? Heyu Biological Technology's stock was trading at $0.1026 at the start of the year. Since then, HYBT stock has increased by 33.5% and is now trading at $0.1370. View the best growth stocks for 2025 here. When did Heyu Biological Technology's stock split? Heyu Biological Technology's stock reverse split before market open on Monday, August 14th 2023.The 1-10 reverse split was announced on Monday, August 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Heyu Biological Technology? Shares of HYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Heyu Biological Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Heyu Biological Technology investors own include (PBIB) (PBIB), Goodyear Tire & Rubber (GT), Helix Biopharma (HBPCF), Mood Media (MM), 3M (MMM), NASB Financial (NASB) and LendingTree (TREE). Company Calendar Today7/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolOTCMKTS:HYBT CIK1086303 Webheyubt.com Phone8615859240902Fax858-459-1103Employees6Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$270 thousand Net Margins-453.55% Pretax Margin-449.84% Return on Equity-6.43% Return on Assets-4.43% Debt Debt-to-Equity RatioN/A Current Ratio0.35 Quick Ratio0.34 Sales & Book Value Annual Sales$80 thousand Price / Sales176.81 Cash FlowN/A Price / Cash FlowN/A Book Value$0.38 per share Price / Book0.36Miscellaneous Outstanding Shares103,247,000Free Float11,109,000Market Cap$14.14 million OptionableNot Optionable Beta-17.74 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:HYBT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heyu Biological Technology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heyu Biological Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.